Search for: "Shire US, Inc."
Results 41 - 60
of 103
Sort by Relevance
|
Sort by Date
7 Nov 2014, 5:52 am
Most warnings concern a product’s use – that if you use (or don’t use) the product in a certain way, you are likely to get hurt; and if you follow the warning, you won’t. [read post]
11 Aug 2014, 4:24 am
Paragon Data Systems, Inc., Case No. 12-3025; -3058 (6th Cir., June 25, 2014) (Cleland, J., sitting by designation). [read post]
23 May 2014, 6:08 pm
., Inc., No. 2013-1409 (Fed. [read post]
26 Feb 2013, 11:37 am
Great use of the Jaws theme music too. [read post]
21 Nov 2012, 5:00 am
Pfizer Inc., 58 A.D.3d 138, 141 (N.Y. [read post]
4 Jun 2012, 9:55 pm
Shire Development, LLC et al. v. [read post]
31 May 2012, 7:50 am
Atwood Mobile Products, LLC US7248156 “LP & CO Gas Detectors” 2:12-cv-03234 New Jersey District Court … [read post]
15 Jan 2012, 8:27 pm
Sandoz Inc. 1:12-cv-00040; filed January 6, 2012 in the District Court of Colorado • Plaintiffs: Shire LLC; Supernus Pharmaceuticals, Inc.; Shire Development Inc.; Shire International Licensing B.V.; Amy F.T. [read post]
18 Dec 2011, 3:45 pm
Mylan Pharmaceuticals Inc. et al. 1:11-cv-00201; filed December 15, 2011 in the Northern District of West Virginia • Plaintiffs: Shire LLC; Supernus Pharmaceuticals, Inc.; Shire Development Inc.; Shire International Licensing B. [read post]
27 Jul 2011, 1:01 am
Paddock Laboratories, Inc. [read post]
20 Jul 2011, 4:04 am
: Supreme Court hearing Human Genome Sciences Inc v Eli Lilly and Company (IPKat) Nexium (Esomeprazole) – UK: EWHC: Ranbaxy wins declaration of non-infringement: Ranbaxy v AstraZeneca (IPKat) Olanzapine – Spain: Supreme Court hands down landmark judgment on doctrine of equivalents and TRIPS (Kluwer Patent Blog) OxyContin (Oxycodone) – US: Purdue files patent infringement suit against Sandoz in response to Para IV certification (Patent Docs) Prevacid (Lansoprazole)… [read post]
30 Jun 2011, 5:00 am
Husqvarna, Inc., 390 N.W.2d 363, 366 (Minn. [read post]
11 May 2011, 4:54 am
Allergan, Inc. [read post]
28 Apr 2011, 3:18 pm
At least the state of the art at the time of the plaintiff’s use applies – unknown and later discovered risks are irrelevant. [read post]
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin… [read post]
22 Dec 2010, 12:39 pm
Centocor, Inc. v. [read post]
15 Dec 2010, 2:17 am
General Coming soon: International Classification of traditional medicine by WHO (Spicy IP) Teva Pharma uses online game to promote generic substitution (Patent Baristas) Australia: APO: Success of phase 3 trials ‘obvious’ in view of phase 1 and 2: Genentec, Inc (Patentology) Brazil: Government support to impel Brazil generic market (GenericsWeb) EU: EPO Enlarged Board of Appeal decides Broccoli (G2/07) and Tomatoes (G1/08) – essentially biological breeding… [read post]
12 Dec 2010, 9:47 pm
Shire LLC, Supernus Pharmaceuticals, Inc. et al. v. [read post]
28 Sep 2010, 3:14 pm
Par Pharmaceutical, Inc; Schering-Plough Healthcare Products, Inc. et al. v. [read post]
27 Aug 2010, 2:41 pm
”Shires v. [read post]
